This is an old revision of this page, as edited by Beetstra (talk | contribs) at 15:02, 21 October 2011 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'UNII', 'CAS_number').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:02, 21 October 2011 by Beetstra (talk | contribs) (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'UNII', 'CAS_number').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.045.665 |
Chemical and physical data | |
Formula | C12H15N3O5S |
Molar mass | 313.32 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Amezinium metilsulfate (INN, trade name Regulton) is a sympathomimetic drug used for the treatment of low blood pressure. It has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake.
References
Cardiac stimulants excluding cardiac glycosides (C01C) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adrenergic and dopaminergic agents |
| ||||||||||||||
Phosphodiesterase inhibitors (PDE3I) | |||||||||||||||
Other cardiac stimulants | |||||||||||||||
|
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |